
ONO-RS-082
CAS No. 99754-06-0
ONO-RS-082 ( —— )
产品货号. M27471 CAS No. 99754-06-0
ONO-RS-082 是一种不依赖 Ca2+ 的磷脂酶 A2 抑制剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥356 | 有现货 |
![]() ![]() |
5MG | ¥583 | 有现货 |
![]() ![]() |
10MG | ¥988 | 有现货 |
![]() ![]() |
25MG | ¥1912 | 有现货 |
![]() ![]() |
50MG | ¥3467 | 有现货 |
![]() ![]() |
100MG | ¥5176 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称ONO-RS-082
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述ONO-RS-082 是一种不依赖 Ca2+ 的磷脂酶 A2 抑制剂。
-
产品描述ONO-RS-082 is a Ca2+-independent phospholipase A2 inhibitor.?(In Vitro):ONO-RS-082 at 3.5 μM was able to inhibit epinephrine-stimulated thromboxane production in human platelets.?ONO-RS-082 could also disrupt endosome tubule formation and maintenance of the Golgi complex.
-
体外实验Cell Viability Assay Cell Line:A549 lung epithelial cell lines Concentration:10 μM Incubation Time:2-h pretreatment Result:Completely blocked HXA3-mediated PAO1-induced PMN transepithelial migration. Largely prevented PAO1-induced PGE2 release.
-
体内实验Animal Model:MCT- pulmonary hypertension (PH) rat model Dosage:50 mg/kg/day Administration:Result:Reduced the development of PH in the MCT-PH model for long-term.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number99754-06-0
-
分子量371.86
-
分子式C21H22ClNO3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (268.92 mM)
-
SMILESCCCCCc1ccc(\C=C\C(=O)Nc2cc(Cl)ccc2C(O)=O)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Che L, et al. Feprazone Displays Antiadipogenesis and Antiobesity Capacities in in Vitro 3 T3-L1 Cells and in Vivo Mice. ACS Omega. 2021 Mar 7;6(10):6674-6680.
产品手册




关联产品
-
AC-261066
AC-261066 是一种视黄酸 beta2 (beta2) 受体激动剂 (pEC50: 8.0)。
-
RP 48497
RP 48497 是右佐匹克隆的光降解产物。艾司佐匹克隆用于治疗失眠。
-
LCMV gp33-41 (TFA) (...
LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes.